October 26-27 2020 Boston, MA
DAY 2 / Tuesday October 27th
Use Case: Setting a new record on the pathway from Patient to Diagnostic to Targeted Treatment in Rare Disease
This use case will delve into a neo-natal intensive care unit case at Rady’s Children hospital wherein a collaborative effort leveraging AI to integrate genomic and clinical record information established a new world record for fastest genomic/AI-based diagnosis. Underlying technologies/capabilities to enable the record – and current next frontiers of research will be discussed.
Use Case: Application of AI to Predict a New Class of Novel Synthetic Lethal Targets Leading to More Effective and Safer Oncology Therapeutic Programs
- AI research and insights using the ExpansiveAI platform
- Scalable mining of data connections, testing masses of hypotheses, cognitive computing and ML to discover novel targets
- Bioinformatic filtering, in-silico validation, prioritizing targets aimed at vulnerable cancer cells harboring a specific gene change
- Launching new effective and safer therapeutic programs
Several industry pioneers will lead an audience-wide discussion on a topic that is impacting the industry and patients now. This is your unique opportunity to gain an understanding of how industry peers are innovating This is also a great opportunity to expand your network and possibly find your next partner.